Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Chan: Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment.... (0.14 sec) 

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of …


WM Chan, TYY Lai, AL Wong, DTL Liu, DSC … - British Journal of Ophthalmology, 2007 - bjo.bmj.com
Results: At 1 year, the logMAR best-corrected visual acuity (BCVA) for the
combined PDT with IVTA group changed from 0.62 to 0.61 (p = 0.74), whereas that
for the monotherapy group changed from 0.61 to 0.67 (p = 0.33). The mean ...
Cited by 22 - Related articles - BL Direct - All 5 versions

Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment …


J Marticorena, F Gomez-Ulla, M Fernandez, B … - American journal of ophthalmology, 2006 - Elsevier
To evaluate visual acuity changes and safety of combined treatment with
photodynamic therapy (PDT) and intravitreal triamcinolone acetonide (IVTA) in
myopic eyes with choroidal neovascularization (CNV).
Cited by 23 - Related articles - All 15 versions

[CITATION] Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal …


RF Degenring, JB Jonas - Acta Ophthalmologica Scandinavica, 2005 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 16 - Related articles - All 2 versions

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization six-month results …


WM Chan, TYY Lai, DTL Liu, DSC Lam - Ophthalmology, 2007 - Elsevier
Cited by 39 - Related articles - All 24 versions

Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in …

- prsjournal.com
ML HERNÁNDEZ-ROJAS, H Quiroz-Mercado, … - Retina, 2007 - journals.lww.com
Methods: In this prospective interventional case series, patients were treated
with 2.5 mg of intravitreal bevacizumab and followed for 3 months.
Best-corrected visual acuity (BCVA), optical coherence tomography (OCT), ...
Cited by 34 - Related articles - BL Direct - All 3 versions

Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic …


JM Ruiz-Moreno, F Gomez-Ulla, JA Montero, S … - Eye, 2009 - phx1.medscape.com
New antiangiogenic drugs have been made available to treat subfoveal CNV
secondary to high myopia, although there have not been too many reports yet.
[11-20] The purpose of this pilot study is to evaluate the outcome of ...
Cited by 16 - Related articles - All 8 versions

Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary …


DSC Lam, DTL Liu, DSP Fan, WW Lai, SF So … - Eye, 2004 - nature.com
Prospective, open label, two-centre, noncomparative, interventional case series.
Consecutive patients with juxtafoveal CNV associated with pathologic myopia were
recruited and treated with a standard regimen of PDT with verteporfin. ...
Cited by 17 - Related articles - All 5 versions

Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation …

- prsjournal.com
I Yamamoto, AH Rogers, E Reichel, PA Yates, … - British Journal of Ophthalmology, 2007 - bjo.bmj.com
Results: There were 11 eyes of 9 patients. 5 of 11 eyes had been treated
previously with photodynamic therapy. Pre-injection visual acuity measured 20/50
to 20/100 in 6 eyes and 20/200 or worse in 5 eyes. After a mean follow-up ...
Cited by 77 - Related articles - BL Direct - All 6 versions

Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal …


S Mandal, P Venkatesh, R Sampangi, S Garg - European journal of ophthalmology - ncbi.nlm.nih.gov
PURPOSE: To evaluate the short-term efficacy and safety of intravitreal
bevacizumab in myopic choroidal neovascularization (mCNV). METHODS: In this
noncomparative, consecutive, interventional case series, 12 eyes of 11 ...
Cited by 19 - Related articles - BL Direct - All 3 versions

Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in …


A Pece, M Vadalà, V Isola, D Matranga - American journal of ophthalmology, 2007 - Elsevier
The median follow-up was 32 months (range, 12 to 56 months). Visual acuity (VA)
improved by 1 or more Snellen lines in 18 eyes (37%), decreased in 12 eyes
(24%), and remained stable in 19 eyes (39%). The median number of lines ...
Cited by 8 - Related articles - All 14 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google